Immupharma Share Discussion Threads

[the stinger] 18/11/2021 07:33

5p today then 3p soon after. You were warned.

[nobbygnome] 18/11/2021 07:21

Well so much in this announcement! So the PK study won't start until next year. What have they been doing FFS. Essentially that means there will be no chance of approval of the drug until end 2025 at the earliest assuming all goes well. They also talk about a new pharmacological form of Lupuzor for future trials. Would it not be better to use this improved form in the Lupus study? Why use an inferior form in the study which is pivotal for the future of the drug and the company..

[suze66] 17/11/2021 10:11

Last trade was my small buy to lower my average, let's hope we hear some positive news soon!

[nobbygnome] 16/11/2021 12:50

Even McCarthy wouldn't stoop as low as to lie about the PK trial going ahead.....I guess it's still an open question as to whether the phase III ever actually starts though!

[the stinger] 16/11/2021 12:47

New lows... 3p soon

[the stinger] 15/11/2021 14:19

No trials of any kind have even started!!.. and probably won't be looking at what was promised and total news blackout!. Don't be fooled here, 3p soon on confirmation of no trials.

[nobbygnome] 15/11/2021 11:40

I wonder how the PK study is going; there has been a complete news blackout. IMM might even be a buy if you assume a positive outcome is a definite.....

[the stinger] 11/11/2021 08:18

No news, no trial, nothing remotely as they have promised.. 3p soon!

[1ultimate] 09/11/2021 23:33

I’m assuming we’ll find out within the next day or two. Could easily rocket to 20p on the next news 🤞

[the stinger] 27/10/2021 10:42

David Gruan... LOL

[david gruen] 26/10/2021 12:40

He's a top trader that stinger....

[the stinger] 22/10/2021 15:36

Short this dog... 3p

[the stinger] 15/10/2021 08:16

Not long for 3p..

[the stinger] 06/10/2021 16:26

How they are getting away with this is amazing!!.

[nobbygnome] 05/10/2021 21:57

BTW thanks for the link s_k!

[nobbygnome] 05/10/2021 21:56

Dear oh dear, you would have thought good old Tim hadn't been involved in the company previously as lack of any tangible progress appears to be everyone else's fault. The fact that he has been chairman for many years seems to have escaped his mind!

So lots of corporate speak but essentially they have made a load of people redundant, shrunk the number of projects and delisted from Euronext in a desperate attempt to save money. From personal knowledge of very similar reorganisations in biotech I doubt very much whether the French subsidiary is all sweetness and light. I suspect that the UK management is widely hated!

He also seemed to downplay the importance of Lupuzor probably recognising the fact that any positive outcome (other than the PK study) is years away. Of course the proof of the pudding is in the eating and I will keep an open mind to see what news comes along as promised!

[geraldus] 30/9/2021 09:01

Congratulations to Sylviane Muller on todays announcement.Quite an achievement.